相关实验视频
Updated: May 23, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
36.9K
一种非典型的动脉动脉基因化基因,可促进晚期动脉样硬化和肝脏脂质生成
Omar El Bounkari1, Chunfang Zan2, Bishan Yang2
1Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), LMU Klinikum, Ludwig Maximilian University (LMU) Munich, Munich, Germany. Omar.El_Bounkari@med.uni-muenchen.de.
Nature communications
|March 7, 2025
概括
巨细胞迁移抑制因子-2 (MIF-2) 驱动动动脉硬化和肝脏脂肪的积累. 阻止MIF-2可降低血管炎症并改善脂质水平,为心血管疾病提供新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 炎症和免疫学 炎症和免疫学
- 代谢疾病 代谢疾病
背景情况:
- 动脉样硬化是一种由脂质驱动的动脉炎症,导致心脏病发作和中风.
- 细胞因子和化学因子是动脉样硬化炎症过程中的关键调解者.
研究的目的:
- 确定动脉样硬化和相关的代谢功能障碍的新分子标.
- 为了研究D-多巴克罗姆复合酶/巨细胞迁移抑制因子-2 (MIF-2) 在动脉生成和肝脂代谢中的作用.
主要方法:
- 在动脉样硬化研究中使用过多脂血症的Apoe-/-小鼠模型.
- 采用了Mif-2缺乏和药物阻断策略.
- 进行了肝脏转录组学,脂组学,肝细胞培养和FLIM-FRET显微镜.
- 分析患者样本,包括冠状动脉疾病患者的状斑块和血.
主要成果:
- 在小鼠中,MIF-2 缺乏和阻塞显著减少了动脉样硬化病变的形成和血管炎症.
- 阻断MIF-2导致血脂水平降低,并通过抑制脂质生成抑制肝脏脂质积累.
- 确定了CXCR4作为MIF-2的受体,通过PI3K/AKT信号传递调解其益动脉和脂质效应.
- 人类动脉样硬化斑块中MIF-2的升高调节,与疾病严重程度相关.
结论:
- MIF-2作为一种非典型的化学激素,促进动脉样硬化和肝脏脂质积累.
- 针对MIF-2提供了一种潜在的心血管疾病治疗策略,通过解决血管炎症和代谢功能障碍.
- 在动脉样硬化病变发生过程中,MIF-2代表了炎症和代谢途径之间的新联系.
相关概念视频
Inflammation
52.2K
Overview
52.2K
Cholesterol: Significance and Regulation
492
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
492
Overview of Lipid Metabolism
914
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
914
Lipid-derived Compounds in the Human Body
4.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K

